A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products
暂无分享,去创建一个
M. Zaki | Sana Aslam | Matloob Ahmad | N. Mohsin | Ayesha Rafiq | U. Ashfaq | S. Al-Hussain | Tooba Jabeen
[1] P. Longo,et al. Drugs for COVID-19: An Update , 2022, Molecules.
[2] M. Bouachrine,et al. Computational approach investigation bioactive molecules from Saussurea Costus plant as SARS-CoV-2 main protease inhibitors using reverse docking, molecular dynamics simulation, and pharmacokinetic ADMET parameters , 2022, Computers in Biology and Medicine.
[3] Leonomir Córdoba-Tovar,et al. Scientific production on medicinal plants and their efficacy against Covid-19: A review and scientometric analysis based on VOSviewer , 2022, Acta Ecologica Sinica.
[4] Jang-Gi Choi,et al. Mulberrofuran G, a Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor , 2022, Nutrients.
[5] Young Soo Kim,et al. Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction , 2022, International journal of molecular sciences.
[6] Vicente Amirpasha Tirado Kulieva,et al. Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19 , 2022, Heliyon.
[7] L. M. França,et al. Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies , 2022, Pharmaceuticals.
[8] Zhiwei Chen,et al. Broad‐spectrum antiviral activity of Spatholobus suberectus Dunn against SARS‐CoV‐2, SARS‐CoV‐1, H5N1, and other enveloped viruses , 2022, Phytotherapy research : PTR.
[9] Mithun Chakraborty,et al. Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19 , 2022, European Journal of Medicinal Chemistry Reports.
[10] A. Mahdi,et al. Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS‐CoV‐2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals , 2022, Journal of food biochemistry.
[11] Morad Mustafa,et al. Phytochemicals As a Potential Inhibitor of COVID-19: An In-Silico Perspective , 2022, Russian Journal of Physical Chemistry A.
[12] I. Yahia,et al. In vitro Anti SARS-CoV-2 Activity and Docking Analysis of Pleurotus ostreatus, Lentinula edodes and Agaricus bisporus Edible Mushrooms , 2022, Infection and drug resistance.
[13] Carolina Q. Sacramento,et al. Commercially Available Flavonols Are Better SARS-CoV-2 Inhibitors than Isoflavone and Flavones , 2022, Viruses.
[14] M. Rashid,et al. Identification of Natural Compounds with Anti-SARS-CoV-2 Activity using Machine Learning, Molecular Docking and Molecular Dynamics Simulation Studies , 2022, Dhaka University Journal of Pharmaceutical Sciences.
[15] E. Ugwuja,et al. A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment , 2022, Frontiers in Medicine.
[16] K. Morita,et al. Anti-SARS-CoV-2 activity of various PET-bottled Japanese green teas and tea compounds in vitro , 2022, Archives of Virology.
[17] O. Santos,et al. Nutraceutical potential of Amazonian oilseeds in modulating the immune system against COVID-19 – A narrative review , 2022, Journal of Functional Foods.
[18] Bahgat Fayed,et al. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS‐CoV‐2 , 2022, Phytotherapy research : PTR.
[19] N. Nhung,et al. Theoretical study on inhibitability of some natural alkaloids against influenza virus hemagglutinin and SARS‐CoV‐2 main protease , 2022, Vietnam Journal of Chemistry.
[20] O. Fidan,et al. In silico evaluation of food‐derived carotenoids against SARS‐CoV‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID‐19 , 2022, Journal of food biochemistry.
[21] N. Dharani,et al. Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529. , 2022, Journal of Infection and Public Health.
[22] O. F. Onifade,et al. Therapeutic capability of five active compounds in typical African medicinal plants against main proteases of SARS-CoV-2 by computational approach , 2022, Informatics in Medicine Unlocked.
[23] M. Bouachrine,et al. In silico investigation of phytoconstituents from Cameroonian medicinal plants towards COVID-19 treatment , 2022, Structural Chemistry.
[24] M. A. E. Abd El Hafez,et al. Characterization, in-silico, and in-vitro study of a new steroid derivative from Ophiocoma dentata as a potential treatment for COVID-19 , 2022, Scientific Reports.
[25] A. Muhammad,et al. Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges , 2022, Phytomedicine Plus.
[26] Daniela Iaconis,et al. Natural Compounds Inhibit SARS-CoV-2 nsp13 Unwinding and ATPase Enzyme Activities , 2022, ACS pharmacology & translational science.
[27] B. Tùng,et al. In silico screening of natural antivirals as potential inhibitors of SARS‐CoV‐2 virus , 2022, Vietnam Journal of Chemistry.
[28] C. Angione,et al. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS‐CoV‐2 wild‐type and the variants of concern, viral cell‐entry process, and cytokine storm in COVID‐19 , 2022, Journal of cellular biochemistry.
[29] L. Guruprasad,et al. Computational studies on the design of NCI natural products as inhibitors to SARS-CoV-2 main protease , 2022, Journal of biomolecular structure & dynamics.
[30] M. Ali,et al. Assaying for antiviral activity of the folkloric medicinal desert plant Rhazya stricta on coronavirus SARS-CoV-2 , 2022, Biotechnology & Biotechnological Equipment.
[31] S. Sarafianos,et al. Marine Natural Products as Leads against SARS-CoV-2 Infection , 2022, Journal of natural products.
[32] V. Eyupoglu,et al. Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (Mpro) inhibitors to unveil a hope against COVID-19 , 2022, Computers in Biology and Medicine.
[33] S. K. Pattanayak,et al. Evaluation of binding performance of bioactive compounds against main protease and mutant model spike receptor binding domain of SARS-CoV-2: Docking, ADMET properties and molecular dynamics simulation study , 2022, Journal of the Indian Chemical Society.
[34] I. Haq,et al. Identification of phytochemical inhibitors of SARS-CoV-2 protease 3CLpro from selected medicinal plants as per molecular docking, bond energies and amino acid binding energies , 2022, Saudi Journal of Biological Sciences.
[35] Ying Chen,et al. Identification of potential target endoribonuclease NSP15 inhibitors of SARS‐COV‐2 from natural products through high‐throughput virtual screening and molecular dynamics simulation , 2022, Journal of food biochemistry.
[36] W. Dehaen,et al. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from Artemisia spp. , 2022, Molecules.
[37] Imen Souid,et al. In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRp , 2022, Saudi Pharmaceutical Journal.
[38] G. Gao,et al. Target-Based Virtual Screening and LC/MS-Guided Isolation Procedure for Identifying Phloroglucinol-Terpenoid Inhibitors of SARS-CoV-2 , 2022, Journal of natural products.
[39] R. Ahmad,et al. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. , 2022, Journal of food biochemistry.
[40] Ziyuan Wang,et al. Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection , 2022, bioRxiv.
[41] S. Gordon,et al. SARS-CoV-2 Variants, Vaccines, and Host Immunity , 2022, Frontiers in Immunology.
[42] S. Jose,et al. Potential of phytocompounds from Brassica oleracea targeting S2-domain of SARS-CoV-2 spike glycoproteins: Structural and molecular insights , 2022, Journal of Molecular Structure.
[43] A. Macabeo,et al. In Silico Triple Targeting of SARS-CoV-2 3CLᵖʳᵒ, PLᵖʳᵒ, and RdRp by Philippine Antitubercular Natural Products Libraries , 2021, The Philippine journal of science.
[44] M. Mustofa,et al. Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs , 2021, Heliyon.
[45] Bharti,et al. Potential inhibitors and plant based technology: An alternative approach to treat corona virus , 2021, Bioorganic Chemistry.
[46] S. Kanaya,et al. Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2 , 2021, FEBS open bio.
[47] M. Kampa,et al. Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs , 2021, Molecules.
[48] Senthil Renganathan,et al. In silico identification of potential inhibitors against main protease of SARS-CoV-2 6LU7 from Andrographis panniculata via molecular docking, binding energy calculations and molecular dynamics simulation studies , 2021, Saudi Journal of Biological Sciences.
[49] M. Shahzad,et al. Isolation of phytochemicals from Malva neglecta Wallr and their quantum chemical, molecular docking exploration as active drugs against COVID-19 , 2021, Journal of Saudi Chemical Society.
[50] A. Hussain,et al. In silico screening, SAR and kinetic studies of naturally occurring flavonoids against SARS CoV-2 main protease , 2021, Arabian Journal of Chemistry.
[51] Nguyễn Tấn Khanh,et al. In silico studies of natural products from medicinal plants to identify potential inhibitors for SARS‐CoV‐2 3C‐like protease , 2021, Vietnam Journal of Chemistry.
[52] S. Durdağı,et al. Instant determination of the artemisinin from various Artemisia annua L. extracts by LC‐ESI‐MS/MS and their in‐silico modelling and in vitro antiviral activity studies against SARS‐CoV‐2 , 2021, Phytochemical analysis : PCA.
[53] Elias Mossialos,et al. The Relationship Between the COVID-19 Pandemic and Vaccine Hesitancy: A Scoping Review of Literature Until August 2021 , 2021, Frontiers in Public Health.
[54] Muhammad I. Ismail,et al. Pimenta dioica (L.) Merr. Bioactive Constituents Exert Anti-SARS-CoV-2 and Anti-Inflammatory Activities: Molecular Docking and Dynamics, In Vitro, and In Vivo Studies , 2021, Molecules.
[55] A. Ramazani,et al. In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds , 2021, Natural product research.
[56] A. Firoz,et al. Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach , 2021, Saudi Journal of Biological Sciences.
[57] W. Sippl,et al. An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants , 2021, Frontiers in Pharmacology.
[58] S. Umakanthan,et al. Review of COVID-19 vaccine subtypes, efficacy and geographical distributions , 2021, Postgraduate Medical Journal.
[59] Z. Tu,et al. Aromatic Cadinane Sesquiterpenoids from the Fruiting Bodies of Phellinus pini Block SARS-CoV-2 Spike–ACE2 Interaction , 2021, Journal of natural products.
[60] M. Sahini,et al. In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts , 2021, RSC advances.
[61] A. Ryo,et al. All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity , 2021, Viruses.
[62] Jang-Gi Choi,et al. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor , 2021, International journal of molecular sciences.
[63] R. Preissner,et al. Reynoutria Rhizomes as a Natural Source of SARS-CoV-2 Mpro Inhibitors–Molecular Docking and In Vitro Study , 2021, Pharmaceuticals.
[64] C. Patel,et al. Identification of novel inhibitors of SARS‐CoV‐2 main protease (Mpro) from Withania sp. by molecular docking and molecular dynamics simulation , 2021, J. Comput. Chem..
[65] A. Macabeo,et al. Anti-HIV reverse transcriptase plant polyphenolic natural products with in silico inhibitory properties on seven non-structural proteins vital in SARS-CoV-2 pathogenesis , 2021, Journal of Genetic Engineering and Biotechnology.
[66] H. Jha,et al. Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study , 2021, Journal of biomolecular structure & dynamics.
[67] A. Rauf,et al. Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae , 2021, South African Journal of Botany.
[68] T. Efferth,et al. Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition , 2021, Marine drugs.
[69] Karel Mena-Ulecia,et al. Antiviral Activity of Metabolites from Peruvian Plants against SARS-CoV-2: An In Silico Approach , 2021, Molecules.
[70] Honggang Zhou,et al. Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation , 2021, Frontiers in Pharmacology.
[71] M. Saraf,et al. Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation , 2021, Computers in Biology and Medicine.
[72] G. Padmanaban,et al. Molecular docking and dynamics studies of curcumin with COVID-19 proteins , 2021, Netw. Model. Anal. Health Informatics Bioinform..
[73] V. Patravale,et al. Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant , 2021, Computers in Biology and Medicine.
[74] S. Kaul,et al. Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides , 2021, International Journal of Biological Macromolecules.
[75] M. Ghoneim,et al. Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study , 2021, Molecules.
[76] Abdullah A. Elgazar,et al. Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2 , 2021, South African Journal of Botany.
[77] T. Emran,et al. Appraisals of the Bangladeshi Medicinal Plant Calotropis gigantea Used by Folk Medicine Practitioners in the Management of COVID-19: A Biochemical and Computational Approach , 2021, Frontiers in Molecular Biosciences.
[78] A. Syed,et al. Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection , 2021, Environmental Challenges.
[79] U. Abdelmohsen,et al. Potential of (Citrus nobilis Lour × Citrus deliciosa Tenora) metabolites on COVID-19 virus main protease supported by in silico analysis , 2021, Natural product research.
[80] S. Yalçın,et al. In silico detection of inhibitor potential of Passiflora compounds against SARS-Cov-2(Covid-19) main protease by using molecular docking and dynamic analyses , 2021, Journal of Molecular Structure.
[81] Hezhen Wu,et al. Investigation of Anti-SARS, MERS, and COVID-19 Effect of Jinhua Qinggan Granules Based on a Network Pharmacology and Molecular Docking Approach , 2021, Natural Product Communications.
[82] M. Ali,et al. Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics , 2021, Antibiotics.
[83] S. Sarafianos,et al. Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase , 2021, Microorganisms.
[84] Keun Woo Lee,et al. Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2 , 2021, Frontiers in microbiology.
[85] Ibrahim M. Ibrahim,et al. Dual targeting of cytokine storm and viral replication in COVID-19 by plant-derived steroidal pregnanes: An in silico perspective , 2021, Computers in Biology and Medicine.
[86] T. Efferth,et al. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants , 2021, Computers in Biology and Medicine.
[87] O. Aly,et al. Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2 , 2021, RSC advances.
[88] A. Mahmoodzadeh,et al. Plant‐derived chemicals as potential inhibitors of SARS‐CoV‐2 main protease (6LU7), a virtual screening study , 2021, Phytotherapy research : PTR.
[89] Jie-Li Hu,et al. Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products , 2021, Signal Transduction and Targeted Therapy.
[90] Jin A Shin,et al. The potential of BEN815 as an anti-inflammatory, antiviral and antioxidant agent for the treatment of COVID-19 , 2021, Phytomedicine Plus.
[91] M. Ghaani,et al. Phenylethanoid glycosides as a possible COVID-19 protease inhibitor: a virtual screening approach , 2021, Journal of Molecular Modeling.
[92] Jianguo Wu,et al. Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor , 2021, bioRxiv.
[93] A. Gulbake,et al. COVID-19 vaccines: rapid development, implications, challenges and future prospects , 2021, Human Cell.
[94] G. Strobel,et al. Antiviral Activity of the PropylamylatinTM Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions , 2021, Viruses.
[95] Suliman Khan,et al. In silico analysis of quranic and prophetic medicinals plants for the treatment of infectious viral diseases including corona virus , 2021, Saudi Journal of Biological Sciences.
[96] Jesudass Joseph Sahayarayan,et al. Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties , 2021, Journal of Infection and Public Health.
[97] Abhijit Karmakar,et al. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion , 2021, Virology.
[98] M. Kamal,et al. Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches , 2021, Viruses.
[99] Ziyad Tariq Muhseen,et al. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2 , 2021, Molecules.
[100] W. Cho,et al. Evaluation of Annona muricata Acetogenins as Potential Anti-SARS-CoV-2 Agents Through Computational Approaches , 2021, Frontiers in Chemistry.
[101] Syed Shujait Ali,et al. In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro) , 2021, Phytotherapy research : PTR.
[102] M. Dimopoulos,et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications , 2021, Journal of biomedical science.
[103] P. Saha,et al. In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding , 2021, Heliyon.
[104] T. Tencomnao,et al. Anti-COVID-19 drug candidates: A review on potential biological activities of natural products in the management of new coronavirus infection , 2020, Journal of Traditional and Complementary Medicine.
[105] S. Borwornpinyo,et al. Anti-SARS-CoV-2 Activity of Andrographis paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives , 2020, bioRxiv.
[106] D. Chakravorty,et al. Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants , 2020, Phytomedicine Plus.
[107] Liliana M. Pacureanu,et al. In Silico Study of Some Natural Flavonoids as Potential Agents against COVID-19: Preliminary Results , 2020, Chemistry Proceedings.
[108] R. Bauer,et al. Antiviral activity of plant juices and green tea against SARS‐CoV‐2 and influenza virus , 2020, bioRxiv.
[109] P. Proksch,et al. Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure–activity relationships, molecular modeling and impact on its folk medicinal uses , 2020, RSC advances.
[110] Ziyad Tariq Muhseen,et al. Promising terpenes as SARS-CoV-2 spike receptor-binding domain (RBD) attachment inhibitors to the human ACE2 receptor: Integrated computational approach , 2020, Journal of Molecular Liquids.
[111] T. Asselah,et al. COVID-19: Discovery, diagnostics and drug development , 2020, Journal of Hepatology.
[112] N. Ghosh,et al. Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies , 2020, Journal of Molecular Structure.
[113] M. Le Maréchal,et al. COVID-19 in clinical practice: A narrative synthesis☆ , 2020, Médecine et Maladies Infectieuses.
[114] C. Pané-Farré,et al. Lockdown, quarantine measures, and social distancing: Associations with depression, anxiety and distress at the beginning of the COVID-19 pandemic among adults from Germany , 2020, Psychiatry Research.
[115] A. Kumari,et al. Polypharmacology of some medicinal plant metabolites against SARS-CoV-2 and host targets: Molecular dynamics evaluation of NSP9 RNA binding protein , 2020, Journal of biomolecular structure & dynamics.
[116] A. Oladiji,et al. A systematic review on COVID-19 pandemic with special emphasis on curative potentials of Nigeria based medicinal plants , 2020, Heliyon.
[117] Abu Montakim Tareq,et al. Biochemical and Computational Approach of Selected Phytocompounds from Tinospora crispa in the Management of COVID-19 , 2020, Molecules.
[118] S. Singh,et al. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants – Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) – a molecular docking study , 2020, Journal of biomolecular structure & dynamics.
[119] Papia Chowdhury,et al. Neuroprotective immunity by essential nutrient “Choline” for the prevention of SARS CoV2 infections: An in silico study by molecular dynamics approach , 2020, Chemical Physics Letters.
[120] Deepthi Ramesh,et al. In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2 , 2020, European Journal of Pharmacology.
[121] Priyanka Sharma,et al. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease , 2020, Journal of biomolecular structure & dynamics.
[122] P. Młynarz,et al. Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus , 2020, Journal of Functional Foods.
[123] G. Russo,et al. Roles of flavonoids against coronavirus infection , 2020, Chemico-Biological Interactions.
[124] G. Yahya,et al. In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes , 2020, Environmental Science and Pollution Research.
[125] elmi S. al jawad sayem Mohamed Ahmed fatouma mohamed bdirahman. NATURAL COMPOUNDS FROM DJIBOUTIAN MEDICINAL PLANTS AS INHIBITORS OF COVID-19 BY IN SILICO INVESTIGATIONS , 2020, International Journal of Current Pharmaceutical Research.
[126] Arpit Shukla,et al. Reckoning a fungal metabolite, Pyranonigrin A as a potential Main protease (Mpro) inhibitor of novel SARS-CoV-2 virus identified using docking and molecular dynamics simulation , 2020, Biophysical Chemistry.
[127] Francesco Castelli,et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics , 2020, The Lancet Infectious Diseases.
[128] D. Chakravorty,et al. The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of SARS‐CoV‐2 targets , 2020, Phytotherapy research : PTR.
[129] D. T. Mwanangombo,et al. Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study , 2020, Chemical Physics Letters.
[130] U. Desai,et al. Discovering small-molecule therapeutics against SARS-CoV-2 , 2020, Drug Discovery Today.
[131] C. Isidoro,et al. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic? , 2020, Journal of Traditional and Complementary Medicine.
[132] Papia Chowdhury. In silico investigation of phytoconstituents from Indian medicinal herb ‘Tinospora cordifolia (giloy)’ against SARS-CoV-2 (COVID-19) by molecular dynamics approach , 2020, Journal of biomolecular structure & dynamics.
[133] V. Prajapati,et al. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment , 2020, International Journal of Biological Macromolecules.
[134] Dongqing Wei,et al. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study , 2020, Journal of biomolecular structure & dynamics.
[135] K. Kanakavalli,et al. In Silico computational screening of Kabasura Kudineer - Official Siddha Formulation and JACOM against SARS-CoV-2 spike protein , 2020, Journal of Ayurveda and Integrative Medicine.
[136] Kunqian Yu,et al. Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro , 2020, bioRxiv.
[137] L. Lai,et al. Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro , 2020, bioRxiv.
[138] T. Emran,et al. Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study , 2020, Scientifica.
[139] Mukesh Kumar,et al. Natural Product Compounds in Alpinia officinarum and Ginger are Potent SARS-CoV-2 Papain-like Protease Inhibitors , 2020 .
[140] A. K. Srivastava,et al. On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation , 2020, 2004.03411.
[141] R. Hilgenfeld,et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors , 2020, Science.
[142] Wu Zhong,et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study , 2020, Engineering.
[143] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[144] Qianyun Liu,et al. Emerging coronaviruses: Genome structure, replication, and pathogenesis , 2020, Journal of medical virology.
[145] D. Falzarano,et al. SARS and MERS: recent insights into emerging coronaviruses , 2016, Nature Reviews Microbiology.
[146] A. Mesecar,et al. Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity , 2013, Journal of Virology.
[147] S. Shinde,et al. Natural Product Emerging as Potential SARS Spike Glycoproteins-ACE2 Inhibitors to Combat COVID-19 Attributed by In-Silico Investigations , 2020 .
[148] D. Sigman,et al. Chemical studies of enzyme active sites. , 1975, Annual review of biochemistry.